Xcout Intel
Mighty Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Mighty Therapeutics among drug discovery companies — ranked by similarity to what Mighty Therapeutics actually does, not by market-cap band.
Subscribe to see Mighty Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Mighty Therapeutics
Mighty Therapeutics, formerly known as Stealth BioTherapeutics, focuses on mitochondrial medicine. The company targets mitochondrial dysfunction associated with rare genetic mitochondrial diseases and common diseases of aging through targeted scientific research and treatment development.
Mighty Therapeutics at a glance
Mighty Therapeutics is a drug discovery company. Its most recent funding round, Debt, raised $150M in July 2026. Xcout tracks 1 named person at Mighty Therapeutics, including Reenie McCarthy (CEO).
Mighty Therapeutics leadership
- Reenie McCarthyCEO
Mighty Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Debt | $150M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Mighty Therapeutics competitors
Ranked by semantic similarity — how close each company is to Mighty Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
LUCA Science is a pre-clinical stage biotechnology company that develops functional mitochondria as therapeutic agents to treat damaged tissues and organs. The company utilizes a proprietary method to isolate functional mitochondria, combining it with advanced drug delivery and formulation technology to create storable biopharmaceutical agents.
Similar drug discovery company
Retro Biosciences is a biotechnology research company based in Redwood City, California, that develops therapies targeting aging biology. Its goal is to extend healthy human lifespan by 10 years.
Similar drug discovery company
Promise Bio is a biotechnology research startup transforming immune-mediated disease treatment with advanced precision therapies. Headquartered in Tel Aviv, Israel, the company emerged from stealth following a seed investment.
Similar drug discovery company
Immitra Bio GmbH is a biotechnology startup and ETH Zürich spin-off developing a scalable in-vivo genetic medicine platform to treat rare genetic diseases. Headquartered in Schlieren, Switzerland, the company secured early-stage venture funding to advance its gene-editing therapies.
Similar drug discovery company
Courage Therapeutics, Inc. is a for-profit biotechnology company founded in 2019 and headquartered in Newton, Massachusetts. The company operates in the biotech sector with a focus on developing therapeutic solutions.
Similar drug discovery company
VectorY Therapeutics is a fully integrated gene therapy company founded in August 2020 and based in Amsterdam, Netherlands. The company is focused on developing novel gene therapies, including clinical trials for conditions like amyotrophic lateral sclerosis (ALS).
Similar drug discovery company
Orbital Therapeutics is a biotechnology company developing RNA medicines, with a focus on engineered circular RNA and delivery technologies. Its programs are intended to address diseases that may benefit from durable, programmable protein expression, serving patients and healthcare providers through potential therapeutic products.
Similar drug discovery company
PAQ Therapeutics is a clinical-stage biotechnology company that utilizes autophagy to develop small-molecule KRAS degraders for the treatment of lethal cancers. The company's research focuses on restoring health and curing diseases that currently lack effective treatment options.
Similar drug discovery company
Founded in 2021 and headquartered in Shenzhen, China, MagicRNA Biotechnology Co., Ltd. is a clinical-stage biotechnology company focused on nucleic acid drug delivery and the research and development of next-generation mRNA and lipid nanoparticle technologies for the treatment of cancer and infectious diseases.
Biopharma
Glycomine, Inc. is a biotherapeutics company focused on developing replacement therapies and treatments for serious rare genetic diseases, operating out of major life science hubs in San Francisco and Boston.
Similar drug discovery company
Astria Therapeutics, Inc. is a public biopharmaceutical company headquartered in Boston, Massachusetts, dedicated to developing life-changing therapies for patients.
Similar drug discovery company
Vima Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. The firm pioneers treatments for dystonia and related movement disorders, focusing on novel oral therapies. It develops specialized therapeutics designed to help patients regain mobility and freedom of movement.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Mighty Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Mighty Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →